The European Medicines Agency is seeking feedback on draft guidance that aims to provide “actionable and focused recommendations” for assessing and improving the quality of real-world data (RWD) for regulatory use.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?